A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors
a study on Solid Tumor
Solid Tumor melanoma HR+ breast cancer ovarian cancer prostate cancer colorectal cancer urothelial carcinoma adoptive cell therapy neoantigen T cell receptor T lymphocyte TCR-engineered T cells personalized cell therapy cell therapy immunotherapy gene therapy PD-1 Neoplasms Nivolumab NeoTCR-P1 adoptive cell therapy NeoTCR-P1 NeoTCR-P1 plus nivolumab
Lead Scientist at UC Davis
- Mehrdad Abedi, MD
Professor, Hematology and Oncology. Authored (or co-authored) 51 research publications.